BSX Boston Scientific Corp

P/E 17.9
Forward P/E 13.35
Price/Sales 2.929
Beta 0.575
Div Yield --
Market Cap --

Company Analysis

Latest News

🔴 Boston Scientific is trading 11.46% down today after cutting full-year EPS guidance

Boston Scientific is trading at $39.90, down 11.46%, after cutting full-year adjusted EPS guidance. - On October 28, 2026, Q3 adjusted EPS was $0.73, below...

Boston Scientific's Cyber Wounds Run Deeper Than One Quarter — Can Investors Trust the Recovery Timeline?

Boston Scientific's Cyber Wounds Run Deeper Than One Quarter — Can Investors Trust the Recovery Timeline?

Shares plunged 11.2% to $40.00 as Boston Scientific's October 28 earnings report confirmed what the market feared: an August cyberattack didn't just dent one...

🔴 Boston Scientific is trading 11.23% down in pre-market after lowering its full-year outlook

Boston Scientific is trading 11.23% down in pre-market at $40.00 after its October 28, 2026, earnings report lowered its outlook. - Third-quarter sales were...

🔴 Boston Scientific is trading 5% down in pre-market after lowering its 2026 outlook amid cybersecurity disruption

Boston Scientific is trading 4.90% down at $42.85 after its October 28, 2026, earnings release lowered its full-year outlook. - Third-quarter sales were $5.138...

Boston Scientific beats Q3 2026 expectations despite cybersecurity incident impacting organic growth guidance

Boston Scientific beats Q3 2026 expectations despite cybersecurity incident impacting organic growth guidance

Boston Scientific reported third quarter 2026 net sales of $5.138 billion, up 1.5% year-over-year, and adjusted EPS of $0.73, both exceeding consensus...

Boston Scientific Corp Q3 2026 Earnings Preview: What Analysts Expect on October 28, 2026

Boston Scientific is expected to report Q3 2026 revenue of $4.53 billion and adjusted EPS of $0.59, with its current stock price of $87.25 trading below the...

Boston Scientific Appoints New COO, Announces New Operating Structure

Boston Scientific Appoints New COO, Announces New Operating Structure

Boston Scientific (BSX) announced the promotion of Joe Fitzgerald to the newly created role of Executive Vice President and Chief Operating Officer. In...

Boston Scientific Sets 52-Week Low at $42.60 as Decline Deepens

Boston Scientific Sets 52-Week Low at $42.60 as Decline Deepens

Boston Scientific hit a new 52-week low of $42.60 on Friday, October 2, 2026, extending its decline. Since spring, when the stock traded above $104, it has...

Boston Scientific Target Cut, Wells Fargo Cites Eight-Day Cyberattack

Boston Scientific Target Cut, Wells Fargo Cites Eight-Day Cyberattack

Wells Fargo reduced its price target for Boston Scientific (NYSE:BSX) to $48 from $50. The firm maintained an Equal Weight rating while lowering third-quarter...

🟢 Boston Scientific is trading 4.04% up today after a broader healthcare-sector rebound

Boston Scientific is trading 4.04% higher at $44.72 after a broader healthcare-sector rebound, with defensive rotation supporting the group while major indexes...

🔴 Boston Scientific is trading 4.07% down today after cyberattack put 2026 guidance at risk

Boston Scientific is trading at $43.13 (-4.07%) after management said an eight-day cyberattack disrupted global operations and made third-quarter and full-year...

🔴 Boston Scientific is trading 4.14% down today after withdrawing 2026 guidance following cybersecurity incident

Boston Scientific is trading at $45.82 (-4.14%) after withdrawing its third-quarter and full-year 2026 sales and adjusted-profit forecasts following an August...

Boston Scientific Withdraws Q3 & FY2026 Guidance Due to Cybersecurity Incident

Boston Scientific Withdraws Q3 & FY2026 Guidance Due to Cybersecurity Incident

Boston Scientific announced that a cybersecurity incident first identified on August 25, 2026, is expected to have a material impact on its financial results....

🟢 Boston Scientific is trading 4% up today

Boston Scientific is trading 4.01% up now at $48.72, after a gain with no clearly identified fresh company-specific catalyst. - Available August 31, 2026...

Farallon Capital Reveals New $469M Stake in Boston Scientific

Hedge fund Farallon Capital Management initiated a significant new position in medical device maker Boston Scientific during the first quarter of 2026,...

Boston Scientific shares tumble, hit by global cyberattack and FDA recall

Boston Scientific shares tumble, hit by global cyberattack and FDA recall

Boston Scientific shares fell following disclosures of a global cyberattack and a high-risk product recall. The company identified a cyberattack on August 25...

🔴 Boston Scientific is trading 4.3% down today after a cybersecurity incident disrupted customer-order processing

Boston Scientific is trading at $47.72, down -4.30%, after disclosing a cybersecurity incident identified on August 25, 2026. • The disruption affects...

Boston Scientific Discloses Cybersecurity Incident Disrupting Global Operations and Shipments

Boston Scientific Discloses Cybersecurity Incident Disrupting Global Operations and Shipments

Boston Scientific Corporation has disclosed a cybersecurity incident, identified on August 25, 2026, that is causing a global disruption to its operations. The...

🔴 Boston Scientific is trading 5% down in pre-market after cyberattack disrupted global operations

Boston Scientific is trading at $47.33 (-5.07%) after disclosing a cybersecurity incident detected on August 25, 2026, that disrupted global operations. •...

Steve Cohen's Point72 slashes Boston Scientific (BSX) stake by 90%

In a significant reversal from the prior quarter, Steve Cohen's Point72 Asset Management reduced its stake in medical device maker Boston Scientific (BSX) by...